Parkinson DiseaseBAPP-VRNCT07038603
Feasibility of a Behavioural Activation Protocol to Support People With Parkinson's Enhanced by VR
A study testing BAPP-VR in people with Parkinson Disease, run by Queen's University, Belfast at 1 site in United Kingdom.
Trial summary
The proposed research project will involve developing and testing the feasibility of a 6 week Behavioural Activation (BA) programme for people with Parkinson's Disease, which will be enhanced by Virtual Reality exercise programme. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Parkinson Disease
- What is being tested?
- BAPP-VR
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 13 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 5 Apr 2023to 1 Nov 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Patients with a diagnosis of Idiopathic Parkinson's Disease which has been diagnosed by a neurologist.
- Patients with an early to moderate disease stage Hoehn and Yahr scale 1-3
- Patients with a BERG Balance Scale > 45
- Currently not attending any other rehab programme/participation in another clinical trial
- Able to exercise independently \& mobilise
- No hospitalisation or medication change within the past month
Show all 11Show fewer
- No other serious medical or surgical condition
- Carers:
- Have direct contact with a participant on the BAPP-VR programme in the role of a carer.
- Healthcare staff:
- Have helped in some capacity to facilitate the intervention or referred patients to BAPP-VR
Who cannot join
- Those who are unwilling/unable to provide written consent to participate
- Not receiving another form of psychotherapy
- Actively suicidal
- No other Neurological Condition
- Vision/ auditory impairment.
- Carers and healthcare staff:
- Those who are unwilling/unable to provide written consent to participate
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Assessing the Feasibility of Behavioural Activation (BA) to Support People With Parkinson's Disease Enhanced by a Virtual Reality Exercise Programme
The proposed research project will involve developing and testing the feasibility of a 6 week Behavioural Activation (BA) programme for people with Parkinson's Disease, which will be enhanced by Virtual Reality exercise programme. The aim of the programme will be to support the mental well-being and physical rehabilitation of people with Parkinson's Disease who are known to Marie Curie Outpatient Department (Belfast).
The main question[s] it aims to answer are:
Read more
Is a Behavioural Activation (BA) enhanced by a Virtual Reality exercise programme feasible and can it support the mental well-being and physical rehabilitation of People with Parkinson's Disease ?
Can the potential impacts of the intervention help to reduce anxiety and depression, as well as improve balance, social interaction and adherence to the programme?
Participants will:
- Attend a group for 6 weeks with the addition of an introductory session, for 1.5 hours per session.
- During sessions they will be asked to take part in a Behavioural Activation talking therapy. The aim of the intervention is to engage patients through activation strategies and help support adherence to exercise programmes. Participants will complete 'homework' tasks between sessions.
- In addition to this, the BA intervention will be enhanced by Virtual Reality exercises and participants will complete exercises within the immersive space using a VR headset.
- Data collection will capture any changes in depression, anxiety, balance,social interaction and adherence to the programme.
- The intervention will be carried out in three phases.
Read the detailed description
The research design will be a small-scale feasibility study. The study will use a pre-test and post-test design to assess the feasibility of Behavioural Activation (BA) to support people with Parkinson's Disease enhanced by a Virtual Reality exercise programme.
Aims and objectives:
This research aims to address this gap in the evidence base by developing and testing the feasibility of a Behavioural Activation (BA) enhanced by a Virtual Reality exercise programme for supporting the mental well-being and physical rehabilitation of People with Parkinson's Disease.
- Developing and creating a Behavioural Activation intervention
- Determine recruitment and retention rates
- Test the feasibility of Behavioural Activation (BA) enhanced by Virtual Reality exercise for people with Parkinson' s Disease.
- Pilot technology and methodological procedures
- Explore the potential impacts of the intervention in reducing anxiety and depression, as well as improving balance, social interaction and adherence to the programme.
The study will be conducted under the supervision of the senior Physiotherapist, another physiotherapist and research nurse at the recruiting hospice site, alongside the researcher and other designated members of the clinical team. The intervention will take place in both the clinical setting at the hospice, as well as in the domiciliary setting. Quantitative data will be collected via pre and post-test outcome measures. Qualitative data will supplement findings to assess the acceptability of the intervention, frequency of use, as well as motivation, ease of use within the home setting, adaptation and adherence.
Primary Outcomes:
To test the feasibility of Behavioural Activation (BA) to support people with Parkinson's Disease enhanced by a Virtual Reality exercise programme.
Secondary Outcomes:
The potential benefits of BA enhanced by a Virtual Reality exercise-based programme in reducing depression, anxiety and improving balance, social interaction and adherence to the programme.
Intervention :
Introductory Sessions, training and baseline outcomes The intervention will replace a 6-week rehabilitative exercise intervention programme at the clinic with the addition of BA. Baselines measures will be taken at the introductory session by the senior physiotherapist and/or physio team.
BA intervention led initially by psychotherapist enhanced by VR Participants will complete the 6-week Behaviour Activation BA programme led by the Doctorate of Philosopy (PhD) researcher who is a qualified psychotherapist (British Association of Behavioural \& Cognitive psychotherapies BABCP). Previous VR exercise studies have used a variety of durations and frequencies for similar interventions. The researcher has followed the clinical advice of the head physiotherapist to determine the duration of the intervention in this study. The intervention is a concise and carefully adapted Behavioural Activation for depression treatment protocol by Elkers and Dawson The group sessions will last for 1.5 hours, examples see listed below. Each session will have a psycho-educational element, such as behaviour/mood link (session 2) This session will support participants to create a problems list and consider setting personal goals. As an introduction to VR, participants will have the opportunity to trial out the Cognitive Behavioural Therapy (CBT) relaxation immersive scene during the class. Any issues with technology or practicalities can be discussed plus patients can share initial experiences of use. Participants will be asked to complete 'homework' between sessions and build in the VR exercise element into the structure of their week, this will become progressively more intense as sessions develop. Patients will also receive a pack of resource worksheets for the BA programme sent via email or participants can request a paper copy. The structure is informed by a current online and in-clinic conventional programme delivery run by Marie Curie.
The researcher will carry out the research in three - phases:
Phase 1: Literature Review and intervention development Phase 2: First group intervention (6 participants) Phase 3: Second, third and fourth group intervention ( larger cohort 14 -18 participants - this may be run as 3 separate groups. More refined based on reflection of Phase 2 )
Steps to participant journey:
Step 1: Participants will have the opportunity to receive guidance on the use of the VR equipment (Oculus Quest), as well as being provided with a written and video resource to take home at an introductory session at the Marie Curie Clinic. Pre-test baseline measures will also be taken during this session by qualified psychotherapist. Consent will also be taken. Cares and Healthcare Professionals will also be invited to this session.
Step 2: Patients will meet in a weekly group in person at the Marie Curie Clinic. The Agenda will allow for group discussion/support, Psycho-education BA strategies, training and implementation of VR to enhance the programme and homework setting and reflection. Patients will be encouraged to set goals between sessions and to complete homework using a combination of resources and exercises as well as CBT relaxation techniques.
There are 4 main exercises which encourage patients to use upper and lower limb mobility. To give an example, one of the exercises requires the patient to use upper limb movements to reach and select changing coloured dots. Patients are encouraged to improve their scores as they progress. The setting of the exercise is in an immersive forest scene. VR interventions will be set up and carefully considered, goal orientated and reflected upon weekly.
Step 3: Participants will be invited to take part in semi-structured interviews via Microsoft Teams or phone-call, as well as complete questionnaire and complete post-test outcome measures. Healthcare professionals and carers will be asked to take part in semi-structured interviews to gain their perspective on the intervention.
Study Setting:
Participants will be recruited from the Parkinson's clinic based at Marie Curie, Belfast and through advertising at Parkinson's UK. The clinic offers outpatient physiotherapy support to people with Parkinson's in Northern Ireland. The study will take place at the Marie Curie Clinic.
Participants:
Participants will have a diagnosis of Idiopathic Parkinson's Disease and carers and healthcare staff will also be recruited to gain their perspective on the project.
Recruitment:
Parkinson's UK are advertising for the study in order to meet the recruitment numbers required and acting as the gatekeeper.
After ethical approval a member of the research team will offer a Participant Information Sheet (PIS) to patient, carers and healthcare staff. Patients will be allowed at least 48 hours to consider participation, prior to being asked if they verbally consent to participate.
The physio team will arrange a screening for the inclusion criteria re. physical outcomes.
A member of the research team will call the participant to kindly answer some pre-intervention questions. Once included they will be invited to an introductory session. The research team will also ask the participant to discuss if their carer may be open to attending the introductory session and they will be provided with a PIS and they too will be given 48 hours to verbal consent before being contacted by a member of the research team. Written consent will be given at the introductory session.
Analytical methods and Evaluation
Primary outcomes:
The feasibility of Behavioural Activation (BA) to support people with Parkinson's Disease enhanced by a Virtual Reality exercise programme.
Quantitative data will be analysed to evaluate recruitment and retention capacity. Qualitative data will further inform reasons for drop out rates, acceptability of outcomes measures determined by patient feedback on the level of burden to complete questionnaires, at pre-post data collection, along with monitoring of how many questionnaires are completed and reasons for non-completion. Qualitative data will be managed using the Nvivo V.11 software.
Questionnaires will be distributed to evaluate the acceptability and suitability of the BA intervention enhanced by the Virtual Reality exercise programme, as well use of the VR element and delivery of BA via telecommunication. Semi-structured interviews will also be carried out with patients, carers and physiotherapists involved in the project to evaluate participant response to the intervention. Follow up questions will be evaluated to consider barriers and success of the research and revision made for Phase 3 and 4. Interviews will be digitally recorded. Recordings will be deleted following transcription, and all identifying information will be removed from the transcripts to ensure participant anonymity.
Written informed consent will be secured prior to commencing semi-structured interviews. An experienced qualitative researcher will interview participants to ensure rigour. Interviews will take place via Microsoft Teams for a duration of 45 minutes. Data will be analysed by the researcher using a thematic content analysis. Nvivo V.11 software will be used to manage qualitative data.
Secondary Outcomes:
Baseline measures will be provided to participants during the introductory session. Physical outcomes measures (Berg Balance Scale) will be completed as well as, anxiety (GAD-7) and depression measures Patient Health Questionnaire (PHQ-9). Secondary outcomes will be analysed and evaluated using the Statistical Package for Social Sciences, v20. As this is a feasibility study there is no formal power calculation. Confidence intervals will be provided along with any estimates, and any change in outcome scores between baseline (prior to the intervention), and post intervention outcomes. Adherence rates will also be analysed and evaluated post intervention.
Quantitative data using outcome measures; Berg Balance Scale, PHQ-9 and GAD-7 will be collected pre and post-test, as well as recruitment (number of participants at the beginning of the study) and retention (numbers that complete the study).
Descriptive statistics including means and standard deviations will be gathered at each time point for each outcome.
Feasibility will be assessed using anxiety and depression as well as balance outcomes; ability to recruit and retain; and fidelity (i.e. consistency of implementation across groups). Acceptability will be assessed by comparing attendance across groups, dropout rates and using through the qualitative methods (interviews and observations) specified to explore (1) reasons for taking part; and (2) user satisfaction.
The quantitative data will be analysed using the Statistical Package for Social Sciences (SPSS), version 25.0 software.
Semi-structured interviews and focus groups will be carried out and evaluated to determine the acceptability and suitability of the BA intervention on secondary outcomes; physical, anxiety and depression, social interaction and adherence. Semi-structured interviews will also be carried out with patients, carers and physiotherapists involved in the project to evaluate participant response to secondary outcomes. Interviews will be digitally recorded. Recordings will be deleted following transcription, and all identifying information will be removed from the transcripts to ensure participant anonymity.
- Conditions
- Parkinson Disease
- Being tested
- BAPP-VR
- Keywords
- anxiety, depression
- Medical subject headings
- Parkinson Disease, Anxiety Disorders, Depression
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
BAPP-VROther
A carefully considered adaptation of a BA protocol enhanced with the use of VR
| Study group | Role | What they receive |
|---|---|---|
| Behavioural Activation enhanced by Virtual Reality exercises | Experimental | Participants will attend a 6 week BA group talking therapy (50mins-1hour) followed by a (30 min) exercise session enhanced with the use of Virtual Reality. Participants will be immersed in a virtual reality forest where they will complete a variety of physio chosen exercises. This intervention will be run in three phases. Receives: Other: BAPP-VR |
What is being measured
The primary outcome is the main question the study is designed to answer.
GAD-7
Anxiety Measure - lower score better outcome - out of possible score of 21
Measured: From enrolment to the end of treatment - week 6
Berg Balance Scale
Balance test - higher score better outcome - out of possible score of 56
Measured: From enrolment to the end of treatment - week 6
PHQ-9
Derpession measure - lower score better outcome -out of possible score of 27
Measured: From enrolment to the end of treatment - week 6
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Jun 2025
- Study start5 Apr 2023
- Primary completion20 Dec 2023
- Study completion1 Nov 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Parkinson DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- The single group study is a small-scale feasibility study using a pre-test and post-test design. All participants will receive the same/ adapted Behavioural Activation (BA) protocol and Virtual Reality exercise programme.
- Masking
- None (open label)
- Enrolment
- 13 participants (actual)
Sponsor and investigators
- Lead sponsor
- Queen's University, Belfast
- Sponsor type
- University, hospital or other
- Collaborators
- Marie Curie Hospice, Belfast, Parkinson's UK
- Responsible party
- Principal investigator, Dr Paul Best, Queen's University, Belfast
- Investigators
- Paul Best, Reader, Principal investigator, Queen's University, Belfast
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07038603
- Sponsor's protocol ID
- B22/27
- Acronym
- BAPP-VR
- Status last verified
- Jun 2025
- First submitted
- 19 Feb 2024
- Last updated
- 26 Jun 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 26 Jun 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Assessing the Feasibility of Behavioural Activation (BA) to Support People With Parkinson's Disease Enhanced by a Virtual Reality Exercise Programme
- ClinicalTrials.gov ID
- NCT07038603
- Acronym / sponsor ID
- BAPP-VR / B22/27
- Conditions
- Parkinson Disease
- Keywords
- anxiety, depression
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 13 participants (actual)
- Lead sponsor
- Queen's University, BelfastUniversity, hospital or other
- Collaborators
- Marie Curie Hospice, Belfast, Parkinson's UK
- Study start
- 5 Apr 2023 (actual)
- Primary completion
- 20 Dec 2023 (actual)
- Study completion
- 1 Nov 2024 (actual)
- First posted
- 26 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The proposed research project will involve developing and testing the feasibility of a 6 week Behavioural Activation (BA) programme for people with Parkinson's Disease, which will be enhanced by Virtual Reality exercise programme. The aim of the programme will be to support the mental well-being and physical rehabilitation of people with Parkinson's Disease who are known to Marie Curie Outpatient Department (Belfast).
The main question[s] it aims to answer are:
Is a Behavioural Activation (BA) enhanced by a Virtual Reality exercise programme feasible and can it support the mental well-being and physical rehabilitation of People with Parkinson's Disease ?
Can the potential impacts of the intervention help to reduce anxiety and depression, as well as improve balance, social interaction and adherence to the programme?
Participants will:
- Attend a group for 6 weeks with the addition of an introductory session, for 1.5 hours per session.
- During sessions they will be asked to take part in a Behavioural Activation talking therapy. The aim of the intervention is to engage patients through activation strategies and help support adherence to exercise programmes. Participants will complete 'homework' tasks between sessions.
- In addition to this, the BA intervention will be enhanced by Virtual Reality exercises and participants will complete exercises within the immersive space using a VR headset.
- Data collection will capture any changes in depression, anxiety, balance,social interaction and adherence to the programme.
- The intervention will be carried out in three phases.
Detailed description
The research design will be a small-scale feasibility study. The study will use a pre-test and post-test design to assess the feasibility of Behavioural Activation (BA) to support people with Parkinson's Disease enhanced by a Virtual Reality exercise programme.
Aims and objectives:
This research aims to address this gap in the evidence base by developing and testing the feasibility of a Behavioural Activation (BA) enhanced by a Virtual Reality exercise programme for supporting the mental well-being and physical rehabilitation of People with Parkinson's Disease.
- Developing and creating a Behavioural Activation intervention
- Determine recruitment and retention rates
- Test the feasibility of Behavioural Activation (BA) enhanced by Virtual Reality exercise for people with Parkinson' s Disease.
- Pilot technology and methodological procedures
- Explore the potential impacts of the intervention in reducing anxiety and depression, as well as improving balance, social interaction and adherence to the programme.
The study will be conducted under the supervision of the senior Physiotherapist, another physiotherapist and research nurse at the recruiting hospice site, alongside the researcher and other designated members of the clinical team. The intervention will take place in both the clinical setting at the hospice, as well as in the domiciliary setting. Quantitative data will be collected via pre and post-test outcome measures. Qualitative data will supplement findings to assess the acceptability of the intervention, frequency of use, as well as motivation, ease of use within the home setting, adaptation and adherence.
Primary Outcomes:
To test the feasibility of Behavioural Activation (BA) to support people with Parkinson's Disease enhanced by a Virtual Reality exercise programme.
Secondary Outcomes:
The potential benefits of BA enhanced by a Virtual Reality exercise-based programme in reducing depression, anxiety and improving balance, social interaction and adherence to the programme.
Intervention :
Introductory Sessions, training and baseline outcomes The intervention will replace a 6-week rehabilitative exercise intervention programme at the clinic with the addition of BA. Baselines measures will be taken at the introductory session by the senior physiotherapist and/or physio team.
BA intervention led initially by psychotherapist enhanced by VR Participants will complete the 6-week Behaviour Activation BA programme led by the Doctorate of Philosopy (PhD) researcher who is a qualified psychotherapist (British Association of Behavioural \& Cognitive psychotherapies BABCP). Previous VR exercise studies have used a variety of durations and frequencies for similar interventions. The researcher has followed the clinical advice of the head physiotherapist to determine the duration of the intervention in this study. The intervention is a concise and carefully adapted Behavioural Activation for depression treatment protocol by Elkers and Dawson The group sessions will last for 1.5 hours, examples see listed below. Each session will have a psycho-educational element, such as behaviour/mood link (session 2) This session will support participants to create a problems list and consider setting personal goals. As an introduction to VR, participants will have the opportunity to trial out the Cognitive Behavioural Therapy (CBT) relaxation immersive scene during the class. Any issues with technology or practicalities can be discussed plus patients can share initial experiences of use. Participants will be asked to complete 'homework' between sessions and build in the VR exercise element into the structure of their week, this will become progressively more intense as sessions develop. Patients will also receive a pack of resource worksheets for the BA programme sent via email or participants can request a paper copy. The structure is informed by a current online and in-clinic conventional programme delivery run by Marie Curie.
The researcher will carry out the research in three - phases:
Phase 1: Literature Review and intervention development Phase 2: First group intervention (6 participants) Phase 3: Second, third and fourth group intervention ( larger cohort 14 -18 participants - this may be run as 3 separate groups. More refined based on reflection of Phase 2 )
Steps to participant journey:
Step 1: Participants will have the opportunity to receive guidance on the use of the VR equipment (Oculus Quest), as well as being provided with a written and video resource to take home at an introductory session at the Marie Curie Clinic. Pre-test baseline measures will also be taken during this session by qualified psychotherapist. Consent will also be taken. Cares and Healthcare Professionals will also be invited to this session.
Step 2: Patients will meet in a weekly group in person at the Marie Curie Clinic. The Agenda will allow for group discussion/support, Psycho-education BA strategies, training and implementation of VR to enhance the programme and homework setting and reflection. Patients will be encouraged to set goals between sessions and to complete homework using a combination of resources and exercises as well as CBT relaxation techniques.
There are 4 main exercises which encourage patients to use upper and lower limb mobility. To give an example, one of the exercises requires the patient to use upper limb movements to reach and select changing coloured dots. Patients are encouraged to improve their scores as they progress. The setting of the exercise is in an immersive forest scene. VR interventions will be set up and carefully considered, goal orientated and reflected upon weekly.
Step 3: Participants will be invited to take part in semi-structured interviews via Microsoft Teams or phone-call, as well as complete questionnaire and complete post-test outcome measures. Healthcare professionals and carers will be asked to take part in semi-structured interviews to gain their perspective on the intervention.
Study Setting:
Participants will be recruited from the Parkinson's clinic based at Marie Curie, Belfast and through advertising at Parkinson's UK. The clinic offers outpatient physiotherapy support to people with Parkinson's in Northern Ireland. The study will take place at the Marie Curie Clinic.
Participants:
Participants will have a diagnosis of Idiopathic Parkinson's Disease and carers and healthcare staff will also be recruited to gain their perspective on the project.
Recruitment:
Parkinson's UK are advertising for the study in order to meet the recruitment numbers required and acting as the gatekeeper.
After ethical approval a member of the research team will offer a Participant Information Sheet (PIS) to patient, carers and healthcare staff. Patients will be allowed at least 48 hours to consider participation, prior to being asked if they verbally consent to participate.
The physio team will arrange a screening for the inclusion criteria re. physical outcomes.
A member of the research team will call the participant to kindly answer some pre-intervention questions. Once included they will be invited to an introductory session. The research team will also ask the participant to discuss if their carer may be open to attending the introductory session and they will be provided with a PIS and they too will be given 48 hours to verbal consent before being contacted by a member of the research team. Written consent will be given at the introductory session.
Analytical methods and Evaluation
Primary outcomes:
The feasibility of Behavioural Activation (BA) to support people with Parkinson's Disease enhanced by a Virtual Reality exercise programme.
Quantitative data will be analysed to evaluate recruitment and retention capacity. Qualitative data will further inform reasons for drop out rates, acceptability of outcomes measures determined by patient feedback on the level of burden to complete questionnaires, at pre-post data collection, along with monitoring of how many questionnaires are completed and reasons for non-completion. Qualitative data will be managed using the Nvivo V.11 software.
Questionnaires will be distributed to evaluate the acceptability and suitability of the BA intervention enhanced by the Virtual Reality exercise programme, as well use of the VR element and delivery of BA via telecommunication. Semi-structured interviews will also be carried out with patients, carers and physiotherapists involved in the project to evaluate participant response to the intervention. Follow up questions will be evaluated to consider barriers and success of the research and revision made for Phase 3 and 4. Interviews will be digitally recorded. Recordings will be deleted following transcription, and all identifying information will be removed from the transcripts to ensure participant anonymity.
Written informed consent will be secured prior to commencing semi-structured interviews. An experienced qualitative researcher will interview participants to ensure rigour. Interviews will take place via Microsoft Teams for a duration of 45 minutes. Data will be analysed by the researcher using a thematic content analysis. Nvivo V.11 software will be used to manage qualitative data.
Secondary Outcomes:
Baseline measures will be provided to participants during the introductory session. Physical outcomes measures (Berg Balance Scale) will be completed as well as, anxiety (GAD-7) and depression measures Patient Health Questionnaire (PHQ-9). Secondary outcomes will be analysed and evaluated using the Statistical Package for Social Sciences, v20. As this is a feasibility study there is no formal power calculation. Confidence intervals will be provided along with any estimates, and any change in outcome scores between baseline (prior to the intervention), and post intervention outcomes. Adherence rates will also be analysed and evaluated post intervention.
Quantitative data using outcome measures; Berg Balance Scale, PHQ-9 and GAD-7 will be collected pre and post-test, as well as recruitment (number of participants at the beginning of the study) and retention (numbers that complete the study).
Descriptive statistics including means and standard deviations will be gathered at each time point for each outcome.
Feasibility will be assessed using anxiety and depression as well as balance outcomes; ability to recruit and retain; and fidelity (i.e. consistency of implementation across groups). Acceptability will be assessed by comparing attendance across groups, dropout rates and using through the qualitative methods (interviews and observations) specified to explore (1) reasons for taking part; and (2) user satisfaction.
The quantitative data will be analysed using the Statistical Package for Social Sciences (SPSS), version 25.0 software.
Semi-structured interviews and focus groups will be carried out and evaluated to determine the acceptability and suitability of the BA intervention on secondary outcomes; physical, anxiety and depression, social interaction and adherence. Semi-structured interviews will also be carried out with patients, carers and physiotherapists involved in the project to evaluate participant response to secondary outcomes. Interviews will be digitally recorded. Recordings will be deleted following transcription, and all identifying information will be removed from the transcripts to ensure participant anonymity.
Study design
- Primary purpose
- Other
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- The single group study is a small-scale feasibility study using a pre-test and post-test design. All participants will receive the same/ adapted Behavioural Activation (BA) protocol and Virtual Reality exercise programme.
| Arm | Type | Receives |
|---|---|---|
| Behavioural Activation enhanced by Virtual Reality exercises | Experimental | Other: BAPP-VRParticipants will attend a 6 week BA group talking therapy (50mins-1hour) followed by a (30 min) exercise session enhanced with the use of Virtual Reality. Participants will be immersed in a virtual reality forest where they will complete a variety of physio chosen exercises. This intervention will be run in three phases. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (11 listed)
- Patients with a diagnosis of Idiopathic Parkinson's Disease which has been diagnosed by a neurologist.
- Patients with an early to moderate disease stage Hoehn and Yahr scale 1-3
- Patients with a BERG Balance Scale > 45
- Currently not attending any other rehab programme/participation in another clinical trial
- Able to exercise independently \& mobilise
Key exclusion criteria (7 listed)
- Those who are unwilling/unable to provide written consent to participate
- Not receiving another form of psychotherapy
- Actively suicidal
- No other Neurological Condition
- Vision/ auditory impairment.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| BAPP-VRA carefully considered adaptation of a BA protocol enhanced with the use of VR | Other | Behavioural Activation enhanced by Virtual Reality exercises |
Primary outcome
GAD-7
Time frame: From enrolment to the end of treatment - week 6
Anxiety Measure - lower score better outcome - out of possible score of 21
Berg Balance Scale
Time frame: From enrolment to the end of treatment - week 6
Balance test - higher score better outcome - out of possible score of 56
PHQ-9
Time frame: From enrolment to the end of treatment - week 6
Derpession measure - lower score better outcome -out of possible score of 27
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Jun 2025.
- Individual participant dataSharing planned: No
Related trials for Parkinson Disease
Not yet recruitingPhase 1/2
STAR0602 With Nivolumab in Non Small Cell Lung Cancer and in Metastatic Castrate-Resistant Prostate Cancer, and STAR0602 Alone in Thymic Carcinoma
NSCLC, Non-Small Cell Lung Cancer
Enrolling by invitationObservational study
Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes
PARKINSON DISEASE (Disorder), Atypical Parkinsonism
RecruitingPhase 3
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Cervical Cancer
Active, not recruitingPhase 1/2
Clinical Safety and Efficacy of Umbilical Cord Mesenchymal Stromal Cells-derived Exosomes in Patients With Parkinson's Disease
Parkinson Disease (PD)
Active, not recruitingObservational study
Adaptive DBS to Offset STN Dysregulation During Exercise in PD
Parkinson Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Paul Best, Reader principal investigator
Queen's University, Belfast
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing BAPP-VR in people with Parkinson Disease, run by Queen's University, Belfast at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 11 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
GAD-7 (time frame: From enrolment to the end of treatment - week 6). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jun 2025.